INTERCEDENT Q4 2015 NEWS

Intercedent was engaged by an Australian trading company to identify a Chinese supplier of bulk cement to the Australian market.

Intercedent was engaged to source capital for a major Australian real estate developer’s projects in Australia.

Intercedent was engaged by a Canadian immunotherapy vaccines company to establish a corporate structure for the company’s business development in Asia, in particular, China.

© 2010 Intercedent | Site by ChinaNetrix